BioSpace News Archive

Business

Novocure Reports Second Quarter 2020 Financial Results and Provides Company Update

Quarterly net revenues of $115.9 million, representing 34 percent growth versus the second quarter 2019 and 14 percent growth versus the first quarter 2020

July 30, 2020
·
11 min read
Business

Cigna Expands Stakeholder and Community Support, Reports Second Quarter 2020 Performance

Global health service company Cigna Corporation continues to expand stakeholder and community support and reported second quarter 2020 performance.

July 30, 2020
·
25 min read
Drug Development

Jardiance® meets primary endpoint in reducing risk of cardiovascular death or hospitalization for heart failure in phase III trial in adults with and without diabetes

Jardiance (empagliflozin) significantly reduced the risk of cardiovascular death or hospitalization for heart failure versus placebo in the EMPEROR-Reduced heart failure trial. The study evaluated adults with heart failure with reduced ejection fraction

July 30, 2020
·
16 min read
Business

Teleflex Reports Second Quarter 2020 Results

Second Quarter Revenues of $567.0 million, down 13.1% versus Prior Year Period; down 12.0% on a Constant Currency Basis

July 30, 2020
·
26 min read
Business

Teleflex Announces Quarterly Dividend - July 30, 2020

Teleflex Incorporated announced that its Board of Directors declared a quarterly cash dividend of thirty-four cents per share of common stock.

July 30, 2020
·
1 min read
Business

Alexion Reports Second Quarter 2020 Results

Achieved goal of establishing ULTOMIRIS® (ravulizumab-cwvz) as new standard of care in PNH with more than 70% patient conversion from SOLIRIS® (eculizumab) in U.S.

July 30, 2020
·
21 min read
Policy

Takeda Announces U.S. FDA Breakthrough Therapy Designation Granted for Pevonedistat for the Treatment of Patients with Higher-Risk Myelodysplastic Syndromes (HR-MDS)

Takeda Pharmaceutical Company Limited announced that the U.S. Food and Drug Administration granted Breakthrough Therapy Designation for its investigational drug pevonedistat for the treatment of patients with higher-risk myelodysplastic syndromes.

July 30, 2020
·
9 min read
Business

ANI Pharmaceuticals Schedules Conference Call to Discuss Second Quarter 2020 Financial Results

ANI Pharmaceuticals, Inc. announced that the Company will release its second quarter 2020 financial results on Thursday, August 6, 2020, before the opening of the U.S. financial markets.

July 30, 2020
·
1 min read
Business

Evelo Biosciences Reports Second Quarter 2020 Financial Results and Business Highlights

Achieved regulatory and ethics authorization for Phase 2 dose ranging trial for EDP1815 in moderate psoriasis in the U.S., UK, and EU; trial initiation expected in 3Q 2020 with interim data expected by mid-2021

July 30, 2020
·
10 min read
Drug Development

RedHill Biopharma Initiates Global Phase 2/3 Study for COVID-19

The global Phase 2/3 study will enroll up to 270 patients with severe COVID-19 across 40 clinical sites; The study has been approved in the UK and Russia and is under review in Italy, Brazil and Mexico

July 30, 2020
·
10 min read